Register
Medicines reference
Product

Unidox Solutab

Doxycycline · CHEPLAPHARM Arzneimittel GmbH

1 form: tablet. No registration in force in Georgia.

Forms and doses0 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Dose Frequency Georgia
100 mg, Tablet 10 mg/kg
Human medicine; extra-label in dogs and cats. Each tablet contains 100 mg doxycycline as doxycycline monohydrate. The current official SmPC requires dispersion of the whole tablet in at least 50 ml water, states that the score line is aesthetic rather than an equal-dose division, and explicitly says this presentation cannot provide a dose below 100 mg. Use another validated doxycycline presentation when the calculated veterinary dose does not reasonably match a whole 100 mg unit; never dry-pill a cat.
· once daily
once daily Georgia Expired
Details: pack, label wording, sources, registration

Unidox Solutab 100 mg, Tablet

dispersible tablet, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Veterinarian-directed treatment of doxycycline-susceptible bacterial infections when oral doxycycline is appropriate and the whole 100 mg dose unit fits the patient
6.9/10
Situational / acceptable
vetman assessment

Unidox Solutab

100 mg, dispersible tablet, human medicine
Assessed clinical scopeDog · Veterinarian-directed treatment of doxycycline-susceptible bacterial infections when oral doxycycline is appropriate and the whole 100 mg dose unit fits the patient · By mouth
Care settingVeterinarian-directed outpatient treatment after patient, infection and dose-form selection; use a different presentation when the required dose is below or materially different from 100 mg.
vetman score 6.9/10 Situational / acceptable
Evidence confidence: Medium Georgia: Expired · № რ-019803 · Verified on 15 Oct 2026 Off-label use

Strong doxycycline evidence does not make this exact 100 mg human unit broadly practical. It is a reasonable extra-label option only when infection and susceptibility support doxycycline and a whole tablet fits the calculated dose.

Regulatory and scientific credibility7.0/10

The exact monohydrate product has a current official regulator-hosted SmPC, package record and authorisation number. It is transparent but authorised for humans, not dogs or cats; the catalogue attribution has been updated to the current holder and exact-product veterinary efficacy is not established.

Clinical efficacy8.0/10

Doxycycline is a well-established guideline-supported treatment for appropriate susceptible canine respiratory, vector-borne and selected skin or systemic infections. The score depends on diagnosis, organism and stewardship and does not transfer the human label infection list to dogs.

Safety and tolerability7.0/10

Appropriately selected doxycycline is generally well tolerated, but gastrointestinal effects, oesophageal injury, photosensitivity and restrictions around pregnancy, immature dentition and significant hepatic disease require selection and monitoring. Exact-product dog safety data are absent.

Clinical practicality5.0/10

Once-daily oral treatment can be workable when a whole 100 mg unit reasonably matches the calculated dose. The score line is not an equal-dose divider and the labelled suspension cannot provide a validated dose below 100 mg, making this form poorly matched to many small and medium dogs.

Full-course cost-effectiveness-

Current comparable full-course local prices were not verified.

Important safety and use flags

  • Use only for a clinically supported doxycycline-susceptible infection. Obtain culture and susceptibility testing whenever the disease site, severity, prior antimicrobial exposure or response makes it appropriate.
  • The 100 mg unit is not divisible for dose purposes. The score line is aesthetic and dispersion does not validate withdrawal of a fractional dose; use another product when the calculated dose does not reasonably match a whole tablet.
  • The human instructions disperse the whole tablet in at least 50 ml water and administer the complete suspension immediately with food. A veterinarian must choose a safer veterinary presentation when that volume or whole dose is unsuitable.
  • Administer with food and adequate fluid according to the selected protocol. Reassess vomiting, dysphagia, regurgitation or another sign of oesophageal or gastrointestinal intolerance.
  • Calcium, magnesium, aluminium, iron, bismuth, antacids, sucralfate and other polyvalent cation sources can reduce doxycycline absorption; separate them according to the applicable protocol.
  • Phenobarbital, phenytoin, carbamazepine, primidone, rifampicin and other enzyme inducers may shorten doxycycline exposure. Review the antimicrobial plan rather than assuming the standard regimen remains adequate.
  • Avoid routine use during pregnancy, lactation and active tooth development unless a veterinarian judges the indication-specific benefit to outweigh the risk and no safer effective option exists.
  • Monitor gastrointestinal tolerance, hydration, clinical response and, for prolonged treatment or relevant comorbidity, liver, renal and haematologic parameters. Stop and reassess severe diarrhoea, dysphagia, jaundice or hypersensitivity.
  • Review concurrent antimicrobials, retinoids, anticoagulants, ciclosporin and methoxyflurane. Product information identifies clinically important combinations, and an interaction check is required before treatment.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Veterinarian-directed treatment of doxycycline-susceptible bacterial infections when oral doxycycline is appropriate and the whole 100 mg dose unit fits the patient
6.3/10
Situational / acceptable
vetman assessment

Unidox Solutab

100 mg, dispersible tablet, human medicine
Assessed clinical scopeCat · Veterinarian-directed treatment of doxycycline-susceptible bacterial infections when oral doxycycline is appropriate and the whole 100 mg dose unit fits the patient · By mouth
Care settingVeterinarian-directed outpatient treatment after patient, infection and dose-form selection; use a different presentation when the required dose is below or materially different from 100 mg.
vetman score 6.3/10 Situational / acceptable
Evidence confidence: Medium Georgia: Expired · № რ-019803 · Verified on 15 Oct 2026 Off-label use

The active ingredient is well supported, but the indivisible 100 mg human unit is poorly matched to most cats. Prefer a validated smaller veterinary or liquid presentation rather than inventing a fractional dose from the dispersion.

Regulatory and scientific credibility7.0/10

The exact monohydrate product has a current official regulator-hosted SmPC, package record and authorisation number. It is transparent but authorised for humans, not dogs or cats; the catalogue attribution has been updated to the current holder and exact-product veterinary efficacy is not established.

Clinical efficacy8.0/10

Doxycycline is a well-established guideline-supported treatment for appropriate susceptible feline respiratory and selected other bacterial infections. Benefit depends on diagnosis, likely organism and stewardship; the score does not authorise indiscriminate empirical use.

Safety and tolerability6.5/10

Dispersion reduces the dry-tablet transit hazard but does not eliminate doxycycline-associated oesophagitis or systemic adverse effects. Feline use still requires reliable fluid or food follow-through, reproductive and dentition caution, and clinical monitoring; exact-product feline safety data are absent.

Clinical practicality2.0/10

Most cats require far below 100 mg at established veterinary regimens. Although dispersion avoids dry-pilling, the exact label forbids treating the score or suspension as a validated fractional dose, so this presentation is generally impractical for feline dose accuracy.

Full-course cost-effectiveness-

Current comparable full-course local prices were not verified.

Important safety and use flags

  • Use only for a clinically supported doxycycline-susceptible infection. Obtain culture and susceptibility testing whenever the disease site, severity, prior antimicrobial exposure or response makes it appropriate.
  • The 100 mg unit is not divisible for dose purposes. The score line is aesthetic and dispersion does not validate withdrawal of a fractional dose; use another product when the calculated dose does not reasonably match a whole tablet.
  • The human instructions disperse the whole tablet in at least 50 ml water and administer the complete suspension immediately with food. A veterinarian must choose a safer veterinary presentation when that volume or whole dose is unsuitable.
  • Never administer this product dry to a cat. Even a dispersed dose requires reliable swallowing and food or fluid follow-through; avoid it in oesophageal disease or when follow-through cannot be assured.
  • Calcium, magnesium, aluminium, iron, bismuth, antacids, sucralfate and other polyvalent cation sources can reduce doxycycline absorption; separate them according to the applicable protocol.
  • Phenobarbital, phenytoin, carbamazepine, primidone, rifampicin and other enzyme inducers may shorten doxycycline exposure. Review the antimicrobial plan rather than assuming the standard regimen remains adequate.
  • Avoid routine use during pregnancy, lactation and active tooth development unless a veterinarian judges the indication-specific benefit to outweigh the risk and no safer effective option exists.
  • Monitor gastrointestinal tolerance, hydration, clinical response and, for prolonged treatment or relevant comorbidity, liver, renal and haematologic parameters. Stop and reassess severe diarrhoea, dysphagia, jaundice or hypersensitivity.
  • Review concurrent antimicrobials, retinoids, anticoagulants, ciclosporin and methoxyflurane. Product information identifies clinically important combinations, and an interaction check is required before treatment.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Doxycycline100 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Registration
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
10 mg/kg
Human medicine; extra-label in dogs and cats. Each tablet contains 100 mg doxycycline as doxycycline monohydrate. The current official SmPC requires dispersion of the whole tablet in at least 50 ml water, states that the score line is aesthetic rather than an equal-dose division, and explicitly says this presentation cannot provide a dose below 100 mg. Use another validated doxycycline presentation when the calculated veterinary dose does not reasonably match a whole 100 mg unit; never dry-pill a cat.
All species Any weight By mouth once daily Product label (SPC)
Active substance doses, with sources
Active substance Doxycycline
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
10 mg/kg Dog, Cat Respiratory Tract Infection; Canine Ehrlichiosis; Leptospirosis; Bacterial Infection; Feline Chlamydiosis By mouth once daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Ronaxan 20 mg tablets for dogs and cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Doxybactin 50 mg tablets for dogs and cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
5 mg/kg
off-label
Dog, Cat Leptospirosis; Respiratory Tract Infection By mouth 2 times daily
ACVIM 2023
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
Updated ACVIM consensus statement on leptospirosis in dogs
Journal of Veterinary Internal Medicine, 2023
ISCAID 2017
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
Antimicrobial Use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats
Journal of Veterinary Internal Medicine, 2017

Known Contraindications

  • Critical
    administration of doxycycline hyclate tablets has been associated with oesophageal erosion.
    Sources: VMD SPC · VMD · ISCAID · JVIM
  • Critical
    Do not use in animals with renal or hepatic insufficiency. Special warnings: None.
    Sources: VMD SPC · VMD
  • Critical
    Product labels differ: some contraindicate doxycycline in hepatic insufficiency, while others advise special caution and monitoring because liver-enzyme increases have been reported. Follow the label of the selected product and monitor hepatic function.
    Sources: Product label
  • Critical
    Do not use doxycycline tablets in animals with vomiting or dysphagia when the product label lists these conditions as contraindications. Other labels advise caution because impaired swallowing or vomiting increases the risk of a tablet lodging in the oesophagus.
    Sources: VMD SPC · VMD
  • Critical
    Do not use doxycycline in puppies or kittens before tooth-enamel formation is complete when the product label lists this as a contraindication. Doxycycline is less likely than other tetracyclines to cause tooth abnormalities because it binds calcium less strongly, but the labelled restriction still applies.
    Sources: VMD SPC · VMD
  • Warning
    Tetracyclines as a class can retard foetal skeletal development (fully reversible) The safety of the veterinary medicinal product has not been established during pregnancy
    Sources: VMD
  • Warning
    The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
    Sources: VMD
  • Warning
    Do not use in animals with known photosensitivity. During treatment, avoid prolonged intense sunlight, particularly in light-coloured or sparsely haired animals, because photosensitivity and photodermatitis may occur.
    Sources: VMD SPC · VMD
  • Warning (Cat)
    Doxycycline tablets and capsules can lodge in the cat oesophagus and cause oesophagitis and stricture (regurgitation, at varying times after the course). Follow every tablet or capsule with a water bolus or food.

Known Drug Interactions

  • Major warning Enrofloxacin + Doxycycline
    Do not combine enrofloxacin with antimicrobials that act antagonistically to quinolones, including macrolides, tetracyclines such as doxycycline, and phenicols such as chloramphenicol.
    Recommendation: Do not administer concurrently. Based on susceptibility testing, choose either a bactericidal fluoroquinolone or a bacteriostatic tetracycline.
    Sources: VMD SPC · VMD
  • Major warning Ampicillin + Doxycycline
    It is not recommended to administer bactericidal and bacteriostatic antibiotics concomitantly.
    Recommendation: If both are required, support the choice with culture and susceptibility results. Otherwise, choose one mechanism.
    Sources: VMD SPC · VMD
  • Major warning Amoxicillin + Doxycycline
    The bactericidal effect of amoxicillin may be inhibited by the concomitant use of bacteriostatic antimicrobials.
    Recommendation: If both are required, support the choice with culture and susceptibility results. Otherwise, choose one mechanism.
    Sources: VMD SPC · VMD
  • Major warning Doxycycline + Phenobarbital
    Phenobarbital, phenytoin, carbamazepine, and other enzyme-inducing antiepileptic drugs can shorten the half-life of doxycycline and reduce its antibacterial exposure. Standard doxycycline dosing may therefore be subtherapeutic.
    Recommendation: If the patient receives phenobarbital and doxycycline is essential, the standard 10 mg/kg dose may be inadequate; monitor clinical response closely. Alternatively, choose an antibiotic from another class based on susceptibility testing.
    Sources: VMD SPC · VMD
  • Major warning Doxycycline + Procaine Benzylpenicillin
    Tetracyclines, chloramphenicol, macrolides, and lincosamides may antagonise the bactericidal action of benzylpenicillin.
    Recommendation: Do not administer concurrently. Choose one mechanism based on susceptibility testing.
    Sources: VMD SPC · VMD
  • Major warning Doxycycline + Sucralfate
    In dogs, concurrent administration of sucralfate suspension reduced doxycycline AUC from 36.0 to 7.2 h·mcg/mL (relative bioavailability 20%). No interaction was detected with sucralfate tablets because tablet fragments were visible in faeces, indicating that the tablets did not disintegrate and were not effective.
    Recommendation: Separate administration by 2 hours: give doxycycline first and sucralfate 2 hours later. With this schedule, bioavailability is 74% and is not statistically different from doxycycline alone.
    Sources: JVPT

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.